approval
saveIBANDRONATE SODIUM — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 243d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 243d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 243d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 243d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 243d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 243d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 243d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 243d ago
same company · ±60 days · 6
- approvalSERTRALINE HYDROCHLORIDE: SERTRALINE HYDROCHLORIDE — FDA approvalMar 14, 2016
- approvalSERTRALINE HYDROCHLORIDE: SERTRALINE HYDROCHLORIDE — FDA approvalMar 14, 2016
- approvalSERTRALINE HYDROCHLORIDE: SERTRALINE HYDROCHLORIDE — FDA approvalMar 14, 2016
- approvalSERTRALINE HYDROCHLORIDE: SERTRALINE HYDROCHLORIDE — FDA approvalMar 14, 2016
- approvalALDACTAZIDE: IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalMar 31, 2016
- approvalALENDRONATE SODIUM: ALENDRONATE SODIUM — FDA approvalApr 8, 2016
comments(0)
5-min edit window · permanent after that